[go: up one dir, main page]

NO20031928L - Nye krystall- og solvatformer av ondansetron-hydroklorid og fremgangmsmåterfor fremstilling derav - Google Patents

Nye krystall- og solvatformer av ondansetron-hydroklorid og fremgangmsmåterfor fremstilling derav

Info

Publication number
NO20031928L
NO20031928L NO20031928A NO20031928A NO20031928L NO 20031928 L NO20031928 L NO 20031928L NO 20031928 A NO20031928 A NO 20031928A NO 20031928 A NO20031928 A NO 20031928A NO 20031928 L NO20031928 L NO 20031928L
Authority
NO
Norway
Prior art keywords
preparation
methods
new crystal
ondansetron hydrochloride
solvate forms
Prior art date
Application number
NO20031928A
Other languages
English (en)
Norwegian (no)
Other versions
NO20031928D0 (no
Inventor
Ramy Lidor-Hadas
Judith Aronhime
Revital Lifshitz
Shlomit Weizel
Valerie Niddam
Original Assignee
Teva Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Teva Pharma filed Critical Teva Pharma
Publication of NO20031928D0 publication Critical patent/NO20031928D0/no
Publication of NO20031928L publication Critical patent/NO20031928L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Steroid Compounds (AREA)
NO20031928A 2000-10-30 2003-04-29 Nye krystall- og solvatformer av ondansetron-hydroklorid og fremgangmsmåterfor fremstilling derav NO20031928L (no)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US24428300P 2000-10-30 2000-10-30
US25381900P 2000-11-29 2000-11-29
US26553901P 2001-01-31 2001-01-31
PCT/US2001/048720 WO2002036558A2 (fr) 2000-10-30 2001-10-30 Nouvelles formes de cristaux et solvates de chlorhydrate d'ondansetron et leurs procedes de preparation

Publications (2)

Publication Number Publication Date
NO20031928D0 NO20031928D0 (no) 2003-04-29
NO20031928L true NO20031928L (no) 2003-06-27

Family

ID=27399743

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20031928A NO20031928L (no) 2000-10-30 2003-04-29 Nye krystall- og solvatformer av ondansetron-hydroklorid og fremgangmsmåterfor fremstilling derav

Country Status (20)

Country Link
US (1) US20020107275A1 (fr)
EP (1) EP1339707A2 (fr)
JP (1) JP2004525083A (fr)
KR (1) KR20030042038A (fr)
CN (1) CN1498216A (fr)
AU (1) AU2002230935A1 (fr)
CA (1) CA2426026A1 (fr)
CZ (1) CZ20031397A3 (fr)
DE (1) DE01991193T1 (fr)
ES (1) ES2204358T1 (fr)
HR (1) HRP20030432A2 (fr)
HU (1) HUP0401239A2 (fr)
IL (1) IL155644A0 (fr)
IS (1) IS6797A (fr)
MX (1) MXPA03003761A (fr)
NO (1) NO20031928L (fr)
PL (1) PL366150A1 (fr)
SK (1) SK6182003A3 (fr)
WO (1) WO2002036558A2 (fr)
YU (1) YU32003A (fr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
YU56103A (sh) * 2001-01-11 2006-05-25 Teva Pharmaceutical Industries Ltd. Poboljšani postupak za pripremanje čistog ondansetron hidrohlorid dihidrata
DE60314400T2 (de) 2002-04-29 2008-02-07 Teva Gyogyszergyar Zartköruen Muködo Reszvenytarsasag Verfahren zur herstellung von 1,2,3,9-tetrahydro-9-methyl-3-[(2-methyl-1h-imidazol-1-yl)methyl]-4h-carbazol-4-on
FI6164U1 (fi) * 2003-01-09 2004-03-15 Synthon Bv Ondansetronmuotoja
WO2006046253A1 (fr) * 2004-10-26 2006-05-04 Ipca Laboratories Limited Procede monotope de preparation de l'agent antiemetique 1,2,3,9-tetrahydro-9-methyl-3[(2-methyl-1h-imidazole-1-yl)methyl]-4h-carbazol-4-one
NZ569984A (en) * 2006-01-27 2011-06-30 Eurand Inc Drug delivery systems comprising weakly basic drugs and organic acids
CA2640460C (fr) * 2006-01-27 2015-05-26 Eurand, Inc Systeme d'administration de medicaments comprenant un agent selectif, faiblement basique bloquant le 5-ht3 de la serotonine et des acides organiques
US20100105724A1 (en) * 2006-12-07 2010-04-29 Helsinn Healthcare Sa Crystalline and amorphous forms of palonosetron hydrochloride
US8133506B2 (en) 2008-03-12 2012-03-13 Aptalis Pharmatech, Inc. Drug delivery systems comprising weakly basic drugs and organic acids
CN102190594A (zh) * 2010-03-17 2011-09-21 上海医药工业研究院 阿戈美拉汀氯化氢水合物及其制备方法
CN102190595A (zh) * 2010-03-17 2011-09-21 上海医药工业研究院 阿戈美拉汀溴化氢水合物及其制备方法
KR102381295B1 (ko) 2013-11-15 2022-03-31 아케비아 테라퓨틱스 인코포레이티드 ｛[5-(3-클로로페닐)-3-하이드록시피리딘-2-카보닐]아미노｝아세트산의 고체형, 이의 조성물 및 용도

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4695578A (en) * 1984-01-25 1987-09-22 Glaxo Group Limited 1,2,3,9-tetrahydro-3-imidazol-1-ylmethyl-4H-carbazol-4-ones, composition containing them, and method of using them to treat neuronal 5HT function disturbances
DE3688296T2 (de) * 1985-03-14 1993-11-04 Beecham Group Plc Arzneimittel zur behandlung von erbrechen.
GB8518741D0 (en) * 1985-07-24 1985-08-29 Glaxo Group Ltd Process
GB8518742D0 (en) * 1985-07-24 1985-08-29 Glaxo Group Ltd Process
GB8630071D0 (en) * 1986-12-17 1987-01-28 Glaxo Group Ltd Medicaments
GB8816187D0 (en) * 1988-07-07 1988-08-10 Glaxo Group Ltd Medicaments
US5344658A (en) * 1989-06-28 1994-09-06 Glaxo Group Limited Process and composition using ondansetron
WO1993000074A1 (fr) * 1991-06-26 1993-01-07 Sepracor, Inc. Methodes et compositions pour le traitement des vomissements, de la nausee et d'autres troubles faisant appel a l'ondansetron optiquement pur r(+)
CA2106642C (fr) * 1992-10-14 2005-08-16 Peter Bod Derives de carbazolone et procede d'obtention
GB9423588D0 (en) * 1994-11-22 1995-01-11 Glaxo Wellcome Inc Compositions
GB9423511D0 (en) * 1994-11-22 1995-01-11 Glaxo Wellcome Inc Compositions
CN1045437C (zh) * 1994-12-29 1999-10-06 中国科学院上海有机化学研究所 恩丹西酮及其生理盐的合成
EP1207160A1 (fr) * 2000-11-20 2002-05-22 Hanmi Pharm. Co., Ltd. Procédé de préparation de la 1,2,3,9-tétrahydro-9-méthyl-3-((2-méthyl-1H-imidazol-1-yl)-méthyl)-4H-carbazol-4-one
DE60314400T2 (de) * 2002-04-29 2008-02-07 Teva Gyogyszergyar Zartköruen Muködo Reszvenytarsasag Verfahren zur herstellung von 1,2,3,9-tetrahydro-9-methyl-3-[(2-methyl-1h-imidazol-1-yl)methyl]-4h-carbazol-4-on
JP2005529908A (ja) * 2002-04-30 2005-10-06 テバ ジョジセルジャール レースベニュタールシャシャーグ オンダンセトロンの新規結晶形、その製法、当該新規形を含有する医薬組成物、及び当該組成物を用いる吐気の治療方法

Also Published As

Publication number Publication date
IS6797A (is) 2003-04-29
WO2002036558A3 (fr) 2003-02-06
MXPA03003761A (es) 2003-07-28
HRP20030432A2 (en) 2004-06-30
SK6182003A3 (en) 2004-03-02
EP1339707A2 (fr) 2003-09-03
CN1498216A (zh) 2004-05-19
HUP0401239A2 (hu) 2004-12-28
DE01991193T1 (de) 2004-07-08
PL366150A1 (en) 2005-01-24
KR20030042038A (ko) 2003-05-27
JP2004525083A (ja) 2004-08-19
IL155644A0 (en) 2003-11-23
CZ20031397A3 (cs) 2003-11-12
AU2002230935A1 (en) 2002-05-15
ES2204358T1 (es) 2004-05-01
YU32003A (sh) 2006-05-25
US20020107275A1 (en) 2002-08-08
CA2426026A1 (fr) 2002-05-10
WO2002036558A2 (fr) 2002-05-10
NO20031928D0 (no) 2003-04-29

Similar Documents

Publication Publication Date Title
NO20022289L (no) Ny anvendelse og nye N-azabisykloamidderivater
IS6934A (is) Nýjar spírótrísýklískar afleiður og notkun þeirrasem fosfódíesterasa-7-hindrar
IS7966A (is) Pyrazól og aðferðir við að búa þau til og notkun þeirra
DK1227088T3 (da) Krystallinsk base af citalopram og hydrochlorid- eller hydrobromidsaltet deraf
NO20041272L (no) Tetracycline derivatives and methods of use thereof
NO20032668L (no) Gyraseinhibitorer og anvendelser derav
NO20014504L (no) Anordning og fremgangsmåte for rehabilitering av tinnitus
IS6477A (is) Afleiður piperazíns og piperadíns
DK1429769T3 (da) Nye formuleringer og anvendelse deraf
NO20033854L (no) N-but-3-enyl-norbuprenorfin og fremgangsmåter for anvendelse
NO20031928L (no) Nye krystall- og solvatformer av ondansetron-hydroklorid og fremgangmsmåterfor fremstilling derav
NO20040266L (no) Nye krystallinske polymorfe former av lerkanidipinhydroklorid og fremgangsmate for fremstilling derav
NO20033251D0 (no) Fremgangsmåte for bestemmelse av den effektive mobilitet og permeabilitet for en formasjon på stedet
NO20011026D0 (no) Matvare og fremgangsmÕte for fremstilling derav
NO20030843D0 (no) Anordning og fremgangsmåte for kultivering
NO20035332D0 (no) Nye heterocykliske derivater og medisinsk anvendelse derav
IS7848A (is) Essítalópram hýdróbrómíð og aðferð til framleiðslu þess
NO20025069L (no) Ny stabil krystall av tiazolidindionderivat og fremgangsmÕte for fremstilling av det samme
NO20030822L (no) Nye forbindelser og fremgangsmåter
PL365272A1 (en) Method and device for fabrication of foundation element
NO20035331D0 (no) Nye heterocyklisk forbindelse og medisinsk anvendelse derav
NO20040479L (no) Solvater av lerkanidipinhydroklorid og nye krystallinske former av lerkanidipinhydroklorid.
NO20030414L (no) Fremgangsmåte for fremstilling av brönnsement og tilhörende testanordning
DK1429770T3 (da) Nye formuleringer og anvendelse deraf
NO20040346L (no) Ny krystall av aryletensulfonamid-derivat og fremstillingsprosess derav

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application